Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Steven Niedelman steps down

This article was originally published in The Gray Sheet

Executive Summary

Deputy Associate Commissioner for Regulatory Operations announces he will retire from FDA at the end of June to become Executive VP at Quintiles Consulting. Niedelman began his career at FDA in 1972 as a consumer safety officer. Before taking the ORA post in 2002, he served as acting director of the Office of Enforcement, where he started as deputy director in July 2001. Early this year, Niedelman was named to a team charged with prioritizing device center initiatives and overseeing the implementation of CDRH's postmarket transformation (1"The Gray Sheet" Jan. 23, 2006, p. 5)...

You may also be interested in...



People In Brief

ACC's new CEO John Lewin: Former California Medical Association CEO John Lewin, MD, assumes the role of chief executive at the American College of Cardiology in September, following ACC's move to Washington, D.C. While at CMA, Lewis led the acquisition of a continuing medical education firm in order to better educate group members. Prior to CMA, the exec founded MEDePass to provide internet confidentiality for physicians. Lewin also oversaw Hawaii's department of health...

FDA Unveils Medical Device “Postmarket Transformation”

FDA's device center is establishing a senior-level team of agency staffers and outside experts to lead an effort to revitalize the postmarket device safety program, the agency announced Jan. 19

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief. 

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel